Drug interactions for the following drug(s)
Applies to: Maxalt 10 MG Oral Tablet <> Suboxone 2/0.5 Sublingual Tablet
Rizatriptan may decrease the excretion rate of Naloxone which could result in a higher serum level.
Applies to: magnesium oxide 400 MG (magnesium 240 MG) Oral Tablet <> Suboxone 2/0.5 Sublingual Tablet
The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Buprenorphine.
Applies to: magnesium oxide 400 MG (magnesium 240 MG) Oral Tablet <> Tylenol 325 MG Oral Tablet
Magnesium oxide can cause a decrease in the absorption of Acetaminophen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Applies to: Tylenol 325 MG Oral Tablet <> Effexor XR 150 MG 24 HR Extended Release Oral Capsule
The metabolism of Acetaminophen can be decreased when combined with Venlafaxine.
Applies to: Tylenol 325 MG Oral Tablet <> Suboxone 2/0.5 Sublingual Tablet
The metabolism of Acetaminophen can be decreased when combined with Buprenorphine.
Applies to: Tylenol 325 MG Oral Tablet <> Maxalt 10 MG Oral Tablet
Acetaminophen may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
Applies to: Maxalt 10 MG Oral Tablet <> Effexor XR 150 MG 24 HR Extended Release Oral Capsule
The risk or severity of adverse effects can be increased when Venlafaxine is combined with Rizatriptan.
Applies to: Effexor XR 150 MG 24 HR Extended Release Oral Capsule <> Suboxone 2/0.5 Sublingual Tablet
Venlafaxine may decrease the excretion rate of Naloxone which could result in a higher serum level.
Applies to: Tylenol 325 MG Oral Tablet <> Levonorgestrel 1.5 MG Oral Tablet
The metabolism of Levonorgestrel can be increased when combined with Acetaminophen.
Applies to: Levonorgestrel 1.5 MG Oral Tablet <> Suboxone 2/0.5 Sublingual Tablet
The metabolism of Buprenorphine can be decreased when combined with Levonorgestrel.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Maxalt 10 MG Oral Tablet <> Suboxone 2/0.5 Sublingual Tablet
Drug1 (rxcui = 213322, name = rizatriptan 10 MG Oral Tablet [Maxalt], tty = SBD). Drug2 (rxcui = 1010608, name = buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet [Suboxone], tty = SBD). Drug1 is resolved to naloxone, Drug2 is resolved to rizatriptan and interaction asserted in DrugBank between Naloxone and Rizatriptan. Drug1 is resolved to buprenorphine, Drug2 is resolved to rizatriptan and interaction asserted in DrugBank between Buprenorphine and Rizatriptan.
Applies to: magnesium oxide 400 MG (magnesium 240 MG) Oral Tablet <> Suboxone 2/0.5 Sublingual Tablet
Drug1 (rxcui = 198741, name = magnesium oxide 400 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1010608, name = buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet [Suboxone], tty = SBD). Drug1 is resolved to buprenorphine, Drug2 is resolved to magnesium oxide and interaction asserted in DrugBank between Buprenorphine and Magnesium oxide.
Applies to: magnesium oxide 400 MG (magnesium 240 MG) Oral Tablet <> Tylenol 325 MG Oral Tablet
Drug1 (rxcui = 198741, name = magnesium oxide 400 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 209387, name = acetaminophen 325 MG Oral Tablet [Tylenol], tty = SBD). Drug1 is resolved to acetaminophen, Drug2 is resolved to magnesium oxide and interaction asserted in DrugBank between Acetaminophen and Magnesium oxide.
Applies to: Tylenol 325 MG Oral Tablet <> Effexor XR 150 MG 24 HR Extended Release Oral Capsule
Drug1 (rxcui = 209387, name = acetaminophen 325 MG Oral Tablet [Tylenol], tty = SBD). Drug2 (rxcui = 729931, name = 24 HR venlafaxine 150 MG Extended Release Oral Capsule [Effexor], tty = SBD). Drug1 is resolved to acetaminophen, Drug2 is resolved to venlafaxine and interaction asserted in DrugBank between Acetaminophen and Venlafaxine.
Applies to: Tylenol 325 MG Oral Tablet <> Suboxone 2/0.5 Sublingual Tablet
Drug1 (rxcui = 209387, name = acetaminophen 325 MG Oral Tablet [Tylenol], tty = SBD). Drug2 (rxcui = 1010608, name = buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet [Suboxone], tty = SBD). Drug1 is resolved to acetaminophen, Drug2 is resolved to buprenorphine and interaction asserted in DrugBank between Acetaminophen and Buprenorphine. Drug1 is resolved to acetaminophen, Drug2 is resolved to naloxone and interaction asserted in DrugBank between Acetaminophen and Naloxone.
Applies to: Tylenol 325 MG Oral Tablet <> Maxalt 10 MG Oral Tablet
Drug1 (rxcui = 209387, name = acetaminophen 325 MG Oral Tablet [Tylenol], tty = SBD). Drug2 (rxcui = 213322, name = rizatriptan 10 MG Oral Tablet [Maxalt], tty = SBD). Drug1 is resolved to acetaminophen, Drug2 is resolved to rizatriptan and interaction asserted in DrugBank between Acetaminophen and Rizatriptan.
Applies to: Maxalt 10 MG Oral Tablet <> Effexor XR 150 MG 24 HR Extended Release Oral Capsule
Drug1 (rxcui = 213322, name = rizatriptan 10 MG Oral Tablet [Maxalt], tty = SBD). Drug2 (rxcui = 729931, name = 24 HR venlafaxine 150 MG Extended Release Oral Capsule [Effexor], tty = SBD). Drug1 is resolved to venlafaxine, Drug2 is resolved to rizatriptan and interaction asserted in DrugBank between Venlafaxine and Rizatriptan.
Applies to: Effexor XR 150 MG 24 HR Extended Release Oral Capsule <> Suboxone 2/0.5 Sublingual Tablet
Drug1 (rxcui = 729931, name = 24 HR venlafaxine 150 MG Extended Release Oral Capsule [Effexor], tty = SBD). Drug2 (rxcui = 1010608, name = buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet [Suboxone], tty = SBD). Drug1 is resolved to naloxone, Drug2 is resolved to venlafaxine and interaction asserted in DrugBank between Naloxone and Venlafaxine. Drug1 is resolved to buprenorphine, Drug2 is resolved to venlafaxine and interaction asserted in DrugBank between Buprenorphine and Venlafaxine.
Applies to: Tylenol 325 MG Oral Tablet <> Levonorgestrel 1.5 MG Oral Tablet
Drug1 (rxcui = 209387, name = acetaminophen 325 MG Oral Tablet [Tylenol], tty = SBD). Drug2 (rxcui = 483325, name = levonorgestrel 1.5 MG Oral Tablet, tty = SCD). Drug1 is resolved to acetaminophen, Drug2 is resolved to levonorgestrel and interaction asserted in DrugBank between Acetaminophen and Levonorgestrel.
Applies to: Levonorgestrel 1.5 MG Oral Tablet <> Suboxone 2/0.5 Sublingual Tablet
Drug1 (rxcui = 483325, name = levonorgestrel 1.5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1010608, name = buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet [Suboxone], tty = SBD). Drug1 is resolved to buprenorphine, Drug2 is resolved to levonorgestrel and interaction asserted in DrugBank between Buprenorphine and Levonorgestrel.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.